Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × One-Lung Ventilation × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1 Lung Diseases 1

Interventions

Cyclophosphamide 1247 Cisplatin 1186 Radiotherapy 1115 Paclitaxel 1107 Carboplatin 1051 Gemcitabine 1027 Docetaxel 962 Bevacizumab 887 Fluorouracil 750 Doxorubicin 676 Capecitabine 636 Dexamethasone 629 Rituximab 621 Oxaliplatin 588 Etoposide 565 pembrolizumab 559 Irinotecan 533 Filgrastim 531 Cytarabine 491 Leucovorin 486 Nivolumab 465 Vincristine 428 Bortezomib 409 Cetuximab 401 Prednisone 398 Erlotinib Hydrochloride 393 Trastuzumab 391 Surveys and Questionnaires 382 Methotrexate 361 Lenalidomide 359

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00534690 2010-01-21

REVOLU

University Hospital, Bordeaux

Phase NA Completed

Lung Diseases, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡